Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Peripheral Artery Disease
Interventions
DRUG

vonapanitase

DRUG

Placebo

Trial Locations (9)

22908

University of Virginia Health System, Charlottesville

32610

UF Health at the University of Florida, Gainesville

49519

Metro Health Hospital, Wyoming

53226

Medical College of Wisconsin, Milwaukee

78756

Cardiothoracic and Vascular Surgeons, Austin

80220

VA Eastern Colorado Healthcare System, Denver

90822

VA Medical Center Long Beach, Long Beach

02118

Boston Medical Center, Boston

02135

Steward St. Elizabeth's Medical, Boston

Sponsors
All Listed Sponsors
lead

Proteon Therapeutics

INDUSTRY